U.S. Market for DeliveryModified Therapeutics Set to Exceed $76 Billion by 2014



Spurred by the success of drug delivery innovations, such as trans-dermal nicotine patches and birth control implants, as well as high demand for technologies to accommodate the pharmacodynamics of newer drug compounds, the U.S. market for drug delivery -modified therapeutics's8212;currently at $23 billion's8212;is poised for rapid growth which could exceed $76 billion by 2014, according to a new report by Kalorama Information, a division of MarketResearch.com.

Advanced Drug Delivery: Technologies, Applications and Markets predicts that while the overall market, which includes delivery devices, will continue to grow at an annual rate of slightly over 7%, the market potential for modified-delivery therapeutics is poised to grow rapidly by more than 18% due primarily to newer therapeutics emerging from the biotech and biopharmaceutical industries, which demand additional means of delivery other than intravenous infusion or frequent injection.

"There are key therapeutic areas in which new drug delivery technologies will have a huge impact," notes Kenneth G. Krul, PhD, the author of the final report. "Expect to see on the horizon oral insulin for diabetics, intradermal microchip delivery, organ-specific delivery, and even drug delivery through the administration of cells designed to produce therapeutic compounds. These and others should prove to be key market drivers."

Focusing solely on the pharmaceutical aspects of drug delivery (not on the device aspects), this study examines the application of advanced drug delivery technology in the improvements of existing pharmaceuticals and the facilitation of the delivery and commercialization of new therapeutics in the cardiovascular, cancer, CNS, diabetes, fertility control, and infectious and pulmonary disease sectors.

Priced at $3,500, this completely updated 2nd Edition of Advanced Drug Delivery can be purchased directly from Kalorama Information by clicking http://www.kaloramainformation.com/pub/1171060.html&xs=r. It is also available at MarketResearch.com.

About Kalorama Information
Kalorama Information, a division of MarketResearch.com supplies the latest in independent market research for the life sciences. For more information, contact Steven Heffner at 212-807-2634 or visit www.KaloramaInformation.com.

About MarketResearch.com
MarketResearch.com is the leading provider of global market intelligence products with over 91,000 research publications available from more than 500 research publishers providing expert insights on global industries. For more information, contact Tom Ehart at 240-747-3014 or visit www.MarketResearch.com.




U.S. Market for DeliveryModified Therapeutics Set to Exceed $76 Billion by 2014



***Note This page is an Archieve of Publicly released information either through our company or another Press Release organization. We do not "fact check", "Support", nor "Dispute" any of the information provided to us. We are a distribution point and Historical press release research and search service. This information only represents the fact that at one point in time the release was distributed to 1000's of publications both online and off. PRNewsNow will not take sides in any personal or commercial disputes you have with the writer of this press release. We will defend its right to exist blindly and without regards to its political, commercial or personal implications.***